Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity
Journal of Thrombosis and Haemostasis · 2024-05 · 22 (5) · 1463-1474
DOI: 10.1016/j.jtha.2024.01.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024-05. Verfasst von Eduarda M Guerreiro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Thrombosis Research Group, Institute of Clinical Medicine, Univesitet i Tromsø - The Arctic University of Norway, Tromsø, Norway. Hauptthemen laut MEDLINE: Blood Platelets, Extracellular Vesicles, Phospholipids, Platelet Activation. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Nord.
Abstract (Originalsprache)
BACKGROUND: Extracellular vesicles (EVs), in particular those derived from activated platelets, are associated with a risk of future venous thromboembolism. OBJECTIVES: To study the biomolecular profile and function characteristics of EVs from control (unstimulated) and activated platelets. METHODS: Biomolecular profiling of single or very few (1-4) platelet-EVs (control/stimulated) was performed by Raman tweezers microspectroscopy. The effects of such EVs on the coagulation system were comprehensively studied. RESULTS: Raman tweezers microspectroscopy of platelet-EVs followed by biomolecular component analysis revealed for the first time 3 subsets of EVs: (i) protein rich, (ii) protein/lipid rich, and (iii) lipid rich. EVs from control platelets presented a heterogeneous biomolecular profile, with protein-rich EVs being the main subset (58.7% ± 3.5%). Notably, the protein-rich subset may contain a minor contribution from other extracellular particles, including protein aggregates. In contrast, EVs from activated platelets were more homogeneous, dominated by the protein/lipid-rich subset (>85%), and enriched in phospholipids. Functionally, EVs from activated platelets increased thrombin generation by 52.4% and shortened plasma coagulation time by 34.6% ± 10.0% compared with 18.6% ± 13.9% mediated by EVs from control platelets (P = .015). The increased procoagulant activity was predominantly mediated by phosphatidylserine. Detailed investigation showed that EVs from activated platelets increased the activity of the prothrombinase complex (factor Va:FXa:FII) by more than 6-fold. CONCLUSION: Our study reports a novel quantitative biomolecular characterization of platelet-EVs possessing a homogenous and phospholipid-enriched profile in response to platelet activation. Such characteristics are accompanied with an increased phosphatidylserine-dependent procoagulant activity. Further investigation of a possible role of platelet-EVs in the pathogenesis of venous thromboembolism is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thrombosis Research Group, Institute of Clinical Medicine, Univesitet i Tromsø - The Arctic University of Norway, Tromsø, Norway.
- Laboratoire Jean Perrin, Institut de Biologie Paris-Seine, Sorbonne Université, Centre National de la Recherche Scientifique, Paris, France. Electronic address: sergei.kruglik@sorbonne-universite.fr.
- L'Institut de Minéralogie, de Physique des Matériaux et de Cosmochimie, Sorbonne Université, Centre National de la Recherche Scientifique, Institut de Recherche pour le Développement, Muséum National d'Histoire Naturell…
- Laboratoire Jean Perrin, Institut de Biologie Paris-Seine, Sorbonne Université, Centre National de la Recherche Scientifique, Paris, France.
- Institute for Lasers, Photonics and Biophotonics and the Department of Chemistry, University at Buffalo, State University of New York, Buffalo, New York, USA.
- Thrombosis Research Group, Institute of Clinical Medicine, Univesitet i Tromsø - The Arctic University of Norway, Tromsø, Norway; Thrombosis Research Center, Division of Internal Medicine, University Hospital of North N…
Förderung
- Helse Nord
Zitieren
APA
Guerreiro, E. M., Kruglik, S. G., Swamy, S., Latysheva, N., Østerud, B., Guigner, J. M., Sureau, F., Bonneau, S., Kuzmin, A. N., Prasad, P. N., Hansen, J. B., Hellesø, O. G., & Snir, O. (2024). Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity. Journal of Thrombosis and Haemostasis, 22(5), 1463-1474. https://doi.org/10.1016/j.jtha.2024.01.004
Vancouver
Guerreiro EM, Kruglik SG, Swamy S, Latysheva N, Østerud B, Guigner JM, et al. Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity. Journal of Thrombosis and Haemostasis. 2024;22(5):1463-1474. doi:10.1016/j.jtha.2024.01.004
BibTeX
@article{Guerreiro2024,
author = {Guerreiro, Eduarda M and Kruglik, Sergei G and Swamy, Samantha and Latysheva, Nadezhda and Østerud, Bjarne and Guigner, Jean-Michel and Sureau, Franck and Bonneau, Stephanie and Kuzmin, Andrey N and Prasad, Paras N and Hansen, John-Bjarne and Hellesø, Olav Gaute and Snir, Omri},
title = {Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
volume = {22},
number = {5},
pages = {1463--1474},
doi = {10.1016/j.jtha.2024.01.004}
}
EUVIMED